一种针对NS3-NS4B相互作用的泛血清型登革热病毒抑制剂
Suzanne J F Kaptein1, Olivia Goethals2, Dominik Kiemel3
1Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Nature
|October 7, 2021
概括
一种名为JNJ-A07的新药对登革热病毒具有很高的效果, 这一发现为治疗登革热和严重的登革热感染提供了有前途的新途径.
科学领域:
- 病毒学
- 药物发现
- 传染性疾病
背景情况:
- 登革热病毒每年造成数以百万计的症状感染,
- 登革热和严重登革热对全球健康构成重大挑战.
研究的目的:
- 描述一种新型,高效的登革热病毒抑制剂JNJ-A07.
- 阐明抗病毒作用机制并评估体内疗效.
主要方法:
- 查登革热病毒抑制剂.
- 生物化学测试以确定作用机制 (NS3-NS4B相互作用).
- 在小鼠模型中进行药物动力学分析和疗效研究.
主要成果:
- JNJ-A07对各种登革热病毒分离体表现出纳米分子到皮克分子活性.
- 该抑制剂通过阻止NS3-NS4B相互作用,一种新的抗病毒机制来阻止病毒复制复合物的形成.
- 在小鼠模型中,JNJ- A07显示出有利的药理动力学和显著的疗效,迅速降低病毒载量.
结论:
- JNJ-A07是一种强大的登革热病毒抑制剂,具有很高的抗性障碍.
- 该药物针对之前未被描述的涉及病毒复制复合物的抗病毒机制.
- JNJ-A07显示出有前途的疗效, 值得进一步开发用于登革热治疗.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58


